Phibro Competitors
| PAHC Stock | USD 41.00 0.31 0.75% |
Phibro Animal vs Mednax Correlation
Very weak diversification
The correlation between Phibro Animal Health and MD is 0.52 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Phibro Animal Health and MD in the same portfolio, assuming nothing else is changed.
Moving against Phibro Stock
Phibro Animal Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Phibro Animal and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Phibro and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Phibro Animal Health does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Phibro Stock performing well and Phibro Animal Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Phibro Animal's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ALVO | 2.90 | 0.03 | 0.01 | 0.09 | 3.17 | 7.89 | 19.51 | |||
| OGN | 2.19 | 0.36 | 0.13 | 0.75 | 2.23 | 6.37 | 20.52 | |||
| BGM | 3.88 | (2.76) | 0.00 | (2.40) | 0.00 | 5.43 | 30.20 | |||
| AVDL | 0.84 | 0.29 | 0.15 | (0.69) | 0.88 | 0.70 | 29.13 | |||
| AUPH | 1.76 | 0.28 | 0.11 | 0.89 | 1.92 | 4.75 | 14.95 | |||
| TLRY | 5.05 | (0.44) | 0.00 | 7.06 | 0.00 | 7.64 | 54.17 | |||
| MNKD | 1.89 | 0.03 | 0.00 | 0.12 | 2.56 | 4.01 | 12.99 | |||
| EVO | 2.53 | 0.17 | 0.06 | 0.21 | 3.05 | 5.72 | 14.66 | |||
| ANIP | 1.46 | (0.18) | 0.00 | (0.41) | 0.00 | 2.77 | 13.39 | |||
| MD | 1.48 | (0.12) | 0.00 | (0.06) | 0.00 | 2.95 | 7.73 |
Phibro Animal Competitive Analysis
The better you understand Phibro Animal competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Phibro Animal's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Phibro Animal's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Phibro Animal Competition Performance Charts
Five steps to successful analysis of Phibro Animal Competition
Phibro Animal's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Phibro Animal Health in relation to its competition. Phibro Animal's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Phibro Animal in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Phibro Animal's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Phibro Animal Health, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Phibro Animal position
In addition to having Phibro Animal in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Management Thematic Idea Now
Management
Companies providing management services to businesses. The Management theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Management Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Phibro Animal Correlation with its peers. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Will Pharmaceuticals sector continue expanding? Could Phibro diversify its offerings? Factors like these will boost the valuation of Phibro Animal. Anticipated expansion of Phibro directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Phibro Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Phibro Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Phibro Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Phibro Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.